Source link : https://www.newshealth.biz/health-news/car-natural-killer-cell-therapy-shows-promise-in-b-cell-lymphomas/
An investigational induced pluripotent stem cell-derived CAR natural killer cell therapy was well tolerated both as monotherapy and in combination with rituximab among patients with B-cell lymphomas, according to results from a phase I first-in-human trial. For the 86 patients included in the study, the maximum tolerated dose of FT596 was not reached, and cytokine […]
Author : News Health
Publish date : 2025-01-13 20:08:29
Copyright for syndicated content belongs to the linked Source.